ciprofloxacin has been researched along with Asthma in 4 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of two new quinolones, ofloxacin and ciprofloxacin and nalidixic acid on serum theophylline level in 17 asthma patients treated with methylxanthines was evaluated." | 5.07 | [Effect of ofloxacin, ciprofloxacin and nalidixic acid on serum theophylline level in patients treated with methylxanthine preparations]. ( Chyrek-Borowska, S; Michalska, I; Siergiejko, Z; Szymański, W, 1992) |
| "A total of 150 patients with COPD, non-CF bronchiectasis or asthma, and P." | 3.11 | Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? ( Alispahic, IA; Andreassen, HF; Armbruster, K; Bangsborg, J; Bodtger, U; Browatzki, A; Christensen, CW; Coia, JE; Datcu, R; Eklöf, J; Ellingsgaard, T; Fenlev, CS; Ghathian, KSA; Gundersen, L; Harboe, ZB; Heidemann, M; Janner, J; Jensen, JUS; Jensen, TT; Johansson, SL; Johnsen, S; Kjærgaard, JL; Lapperre, TS; Linde, H; Moberg, M; Nielsen, TL; Overgaard, RH; Pedersen, L; Rosenvinge, FS; Saeed, MI; Seersholm, N; Sivapalan, P; Sørensen, VM; Titlestad, I; Ulrik, CS; Vijdea, R; Weinreich, UM; Wilcke, T; Østergaard, C, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eklöf, J | 1 |
| Alispahic, IA | 1 |
| Sivapalan, P | 1 |
| Wilcke, T | 1 |
| Seersholm, N | 1 |
| Armbruster, K | 1 |
| Kjærgaard, JL | 1 |
| Saeed, MI | 1 |
| Nielsen, TL | 1 |
| Browatzki, A | 1 |
| Overgaard, RH | 1 |
| Fenlev, CS | 1 |
| Harboe, ZB | 1 |
| Andreassen, HF | 1 |
| Lapperre, TS | 1 |
| Pedersen, L | 1 |
| Johnsen, S | 1 |
| Ulrik, CS | 1 |
| Janner, J | 1 |
| Moberg, M | 1 |
| Heidemann, M | 1 |
| Weinreich, UM | 1 |
| Vijdea, R | 1 |
| Linde, H | 1 |
| Titlestad, I | 1 |
| Johansson, SL | 1 |
| Rosenvinge, FS | 1 |
| Østergaard, C | 1 |
| Ghathian, KSA | 1 |
| Gundersen, L | 1 |
| Christensen, CW | 1 |
| Bangsborg, J | 1 |
| Jensen, TT | 1 |
| Sørensen, VM | 1 |
| Ellingsgaard, T | 1 |
| Datcu, R | 1 |
| Coia, JE | 1 |
| Bodtger, U | 1 |
| Jensen, JUS | 1 |
| Smith-Norowitz, TA | 1 |
| Weaver, D | 1 |
| Norowitz, YM | 1 |
| Hammerschlag, MR | 1 |
| Joks, R | 1 |
| Durkin, HG | 1 |
| Kohlhoff, S | 1 |
| Lilley, LL | 1 |
| Guanci, R | 1 |
| Chyrek-Borowska, S | 1 |
| Siergiejko, Z | 1 |
| Michalska, I | 1 |
| Szymański, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Targeted AntiBiotics for Chronic Pulmonary Disease: Can Targeted Antibiotic Therapy Improve the Prognosis of Pseudomonas Aeruginosa Infected Patients With Chronic Pulmonary Obstructive Disease, Non-cystic Fibrosis Bronchiectasis and Asthma? A Multicenter,[NCT03262142] | Phase 4 | 51 participants (Actual) | Interventional | 2018-01-10 | Terminated (stopped due to Slow recruitment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for ciprofloxacin and Asthma
| Article | Year |
|---|---|
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma?
Topics: Anti-Bacterial Agents; Asthma; beta-Lactams; Bronchiectasis; Ciprofloxacin; Fibrosis; Humans; Predni | 2022 |
[Effect of ofloxacin, ciprofloxacin and nalidixic acid on serum theophylline level in patients treated with methylxanthine preparations].
Topics: Administration, Oral; Adult; Aminophylline; Asthma; Biological Availability; Ciprofloxacin; Drug The | 1992 |
2 other studies available for ciprofloxacin and Asthma
| Article | Year |
|---|---|
Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma.
Topics: Adolescent; Anti-Bacterial Agents; Asthma; Azithromycin; Child; Chlamydophila Infections; Chlamydoph | 2018 |
Avoiding adverse reactions.
Topics: Antacids; Anti-Infective Agents; Asthma; Bronchodilator Agents; Ciprofloxacin; Drug Interactions; Hu | 1996 |